Clinical Study
Recurrence of Retinopathy of Prematurity in Zone II Stage 3+ after Ranibizumab Treatment: A Retrospective Study
Table 2
Multivariate logistic regression analysis of risk factors for the recurrence of retinopathy of prematurity.
| Factor | Odds ratio | value |
| Birth | 0.823 | 0.860 | Gestation | 1.332 | 0.791 | Respiratory distress syndrome | 5.232 | 0.221 | HIE | 3.856E5 | 0.999 | Hypotension | 0.000 | 1.000 | Carbohemia | 0.000 | 1.000 | Placental abruption | 0.000 | 0.999 | Preretinal hemorrhage before treatment | 39.404 | 0.004 | Preretinal hemorrhage after treatment | 0.000 | 0.999 | Iris neovascularization | 7.025E8 | 1.000 | Threshold | 0.773 | 0.883 |
|
|
HIE: hypoxic ischemic encephalopathy.
|